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Abstract
Background: Aim - to survey members of Diabetes UK who had Type 2 diabetes and who used self monitoring of
blood glucose (SMBG), to elicit their views on its usefulness in the management of their diabetes, and how they
used the results. A questionnaire was developed for the Diabetes UK website. The questionnaire was posted on
the Diabetes UK website until over 500 people had responded. Questions asked users to specify the benefits
gained from SMBG, and how these benefits were achieved. We carried out both quantitative analysis and a
thematic analysis for the open ended free-text questions.
Findings: 554 participants completed the survey, of whom 289 (52.2%) were male. 20% of respondents were
recently diagnosed (< 6 months). Frequency of SMBG varied, with 43% of participants testing between once and
four times a day and 22% testing less than once a month or for occasional periods.
80% of respondents reported high satisfaction with SMBG, and reported feeling more ‘in control’ of their diabetes
management using it. The most frequently reported use of SMBG was to make adjustments to food intake or con-
firm a hyperglycaemic episode.
Women were significantly more likely to report feelings of guilt or self-chastisement associated with out of range
readings (p = < .001).
Conclusion: SMBG was clearly of benefit to this group of confirmed users, who used the results to adjust diet,
physical activity or medications. However many individuals (particularly women) reported feelings of anxiety and
depression associated with its use.
Background
A recent review of evidence on self monitoring of blood
glucose (SMBG) in Type 2 diabetes, done to inform the
deliberations of a Department of Health (England)
working group on SMBG, found that the published evi-
dence for effectiveness and cost-effectiveness was weak,
and its value not proven [1]. However the working
group had heard from Diabetes UK that many people
with type 2 diabetes are convinced that SMBG is of
value. The report of the working group is published
http://www.diabetes.nhs.uk/document.php?o=1023 [2].
Some individuals with Type 2 diabetes report the ability
to self-monitor blood glucose levels to be empowering,
enabling them to feel more ‘in control’ of their diabetes
and able to react to readings quickly, rather than having
to wait for their routine HbA1c test [3] Possible benefits
of SMBG include immediate confirmation of hypogly-
caemia or hyperglycaemia; an increase in motivation to
stimulate greater self-care; and data with which patients
or healthcare teams could adjust treatment regimens [3].
However, a recurring theme in the recent review by Clar
and colleagues was that the results were often not used
to adjust treatment.
Given the mismatch between the views of some
patients, and the evidence from trials, it was decided to
seek views from patients who valued SMBG, and in par-
ticular to find out how they used the data, and what
changes they made.
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It was anticipated that a highly selected group of peo-
ple with type 2 diabetes who were SMBG users would
respond, but rather than causing a problem of bias, this
would provide information on why some people found
SMBG valuable.
Methods
A questionnaire was developed and piloted by seven-
teen volunteer service users and healthcare profes-
sionals prior to ‘going live ’ on the Diabetes UK
website. Questions were asked about duration of dia-
betes, frequency, uses and helpfulness of SMBG, about
who provided information about how to use the meter
and interpret results, what actions were taken in
response to high or low blood glucose levels, and how
participants felt when blood glucose results were out
of target range. Forty questions were included with an
estimated completion time of approximately 10-15
minutes. The questionnaire was posted on the Diabetes
UK website from 15th to 28th January 2010. A copy of
the questionnaire is attached as Appendix One.
Statistical analyses were performed using SPSS for
Windows software (version 17). Categorical variables
were analysed using descriptive and inferential statis-
tics. Unless otherwise stated, the chi-square test was
used for all comparisons of the categorical data (statis-
tically significant at P < 0.05). If a 2 × 2 table was pre-
sented, the continuity for correction value was used
and if any cell had an expected count less than 5
the Fisher ’s Exact Test was used. The free text
responses were analysed using thematic analysis. The
quality (including accuracy and completeness) of the
thematic framework was independently checked by a
second researcher. Any discrepancies were resolved by
consensus.
For thematic coding and analyses, the quality check
revealed an overall discrepancy of 5.1%. This figure
represents the number of discrepancies/errors between
the data entered by one researcher and an independent
researcher reviewing the coding framework and consis-
tency check of all data fields.
Results
A total of 555 participants completed the survey. One
participant was excluded as they did not have Type 2
diabetes, leaving 554 participants, of whom 289 (52.2%)
were male. Of those who responded, 98.9% (n = 531)
reported self-monitoring their blood glucose levels (n =
271; 98.2% men and n = 254; 99.6% women). None of
the 1.1% of individuals who reported not self monitoring
gave a reason for not doing so. Duration of diabetes
details are provided in Table 1, with frequency of self-
monitoring of blood glucose and timings of monitoring
presented in Tables 2 and 3 respectively.
Characteristics of Respondents
95.8% (n = 531) of participants were on diet alone or
oral glucose lowering drugs, whilst 4.2% (n = 23) were
using insulin. Of these, 98.9% (n = 525) used their own
meter to test their blood glucose levels. The insulin
users did not continue with the rest of the survey as
they did not meet the inclusion criteria (i.e. Type 2 dia-
betes treated with lifestyle or oral medications).
The frequency of testing varied with the reasons for
doing so, but there was wide variation within each
group. Of the 195 who were testing to monitor control
as they were newly diagnosed, 27.7% (n = 54) tested
once or twice a day, with a further 16.4% (n = 32) test-
ing four or more times a day. Amongst those testing to
make adjustments to food intake, 24.1% monitored
occasionally or less than once a month, but 25.1% (n =
72) tested once or twice a day. Amongst those testing to
assess the impact of physical activity, 24.6% (n = 30)
tested occasionally but over a third, i.e. 36.2% (n = 44)
were testing three or more times a day.
Table 1 Duration of Diabetes
Male Female Total
N % N % N %
0-6 months 57 19.8 54 20.5 111 20.1
Between 6 months and 1 year 36 12.5 20 7.6 56 10.1
Between 1 and 3 years 78 27.1 74 28.0 152 27.5
Between 3 and 5 years 38 13.3 43 16.3 81 14.7
More than 5 years 77 26.7 72 27.2 149 27.0
Don’t know 1 0.3 0 0.0 1 0.2
Prefer not to say 1 0.3 1 0.4 2 0.4
Totals 288 100 264 100 552 100
Table 2 Frequency of SMBG
Male Female Total
Frequency N % N % N %
Once a day 33 12.2 38 15.0 71 13.5
Twice a day 29 10.7 32 12.6 61 11.6
Three times a day 25 9.2 22 8.7 47 9.0
Four times a day 16 5.9 19 7.5 35 6.7
More than four times a day 10 3.7 15 5.8 25 4.8
Once a week 28 10.3 15 5.8 43 8.2
More than once a week but not every
day
52 19.2 39 15.4 91 17.3
Fortnightly 13 4.8 7 2.8 20 3.8
Less than once a month 6 2.2 4 1.6 10 1.9
Occasional periods * 54 19.9 60 23.6 114 21.7
Other 5 1.9 3 1.2 8 1.5
Totals 271 100 254 100 525 100
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Amongst those testing to confirm an episode of hypo-
glycaemia, 35.3% (n = 43) tested less than once a month
or occasionally, but 42% (n = 51) tested one to more than
four times a day, perhaps because they had episodes of
hypoglycaemia. Similarly, amongst those testing to con-
firm hyperglycaemia, 25.6% (n = 72) did so less than once
a month or occasionally but 42.9% (n = 121) tested
between once to more than four times a day. Only 5.9%
(n = 31) tested to alter their medication, whilst 15.5%
(n = 81) tested to assess the effect of new medications.
43.1% of participants were testing their blood glucose
levels between once a day and more than four times a
day, compared with 22.4% (n = 124) who were testing
less than once a month or for occasional periods. Their
results did not differ systematically on the helpfulness
question, nor were frequent user more anxious. It is not
known whether this reflects healthcare professional
advice in terms of testing regimen. Only 7.2% (n = 40,
Table 4) of participants reported using SMBG to deter-
mine whether it is safe to drive.
Uses and Helpfulness of SMBG
Reasons for self-monitoring were varied as can be seen
in Table 4 below. The extent to which participants felt
SMBG was helpful is presented in Table 5 below.
Thus, 83.3% of male (n = 225) and 79.9% (n = 203) of
female respondents scored 7 or above (81.7% total),
indicating a high satisfaction with the usefulness of
SMBG. This was as expected from a group who were
expected to be mainly confirmed users.
Only five responses were received to the question ‘if
you circled 0-4, why don’t you find SMBG helpful?’
Three reported futility of testing e.g. “there is no point
it changes nothing”, “it’s not helpful as you cannot do
anything to bring you levels down ..."; one reported
being demotivated i.e. “Whilst on medication, I found it
dispiriting and demotivating to find that there was no
significant reduction in levels over time”.
There were no significant differences between partici-
pants reporting low helpfulness of SMBG (i.e. 0-4) and
those reporting high helpfulness (i.e. 7-10) in terms of
uses of SMBG, frequency of testing or duration of
Table 3 Typically when do you test your bloods?
Male Female Total
Frequency N % N % N %
Before meals 178 65.7 174 68.5 352 67.0
2 hours after meals 122 45.0 122 48.0 244 46.5
Before going to bed 57 21.0 63 24.8 120 22.9
During episodes of illness 53 19.6 57 22.4 110 21.0
Before I set off to drive 14 5.2 16 6.3 30 5.7
If I feel hypoglycaemic 49 18.1 66 26.0 115 21.9
If I feel hyperglycaemic 68 25.1 98 38.6 166 31.6
Before periods of physical activity 12 4.4 19 7.5 31 5.9
During physical activity 5 1.9 4 1.6 9 1.7
After physical activity 25 9.2 27 10.6 52 9.9
A change to treatment being
considered
19 7.0 17 6.7 36 6.9
Monitor effect of certain foods 74 27.3 88 34.7 162 30.9
Other 42 15.5 39 15.4 81 15.4
Totals 718 - 790 - 1508 -
* Respondents were able to tick more than one answer
Table 4 Uses of SMBG
Male Female Total
Action N % N % N %
Monitor my BG as I have recently been diagnosed with diabetes 100 36.9 95 37.4 195 37.1
Make adjustments to my food intake 140 51.7 146 57.5 286 54.5
When assessing the impact of physical activity 60 22.1 62 24.4 122 23.2
Confirm if I’m having a hypoglycaemic episode 50 18.5 72 28.4 122 23.2
Confirm if I’m having a hyperglycaemic episode 130 48.0 152 59.8 282 53.7
Alter my diabetes medication 22 8.1 9 3.5 31 5.9
Inform me about the effect of a new diabetes medication I’ve started 44 16.2 37 14.6 81 15.4
Inform me about my blood glucose levels during a period of illness 70 25.8 89 35.0 159 30.3
I don’t use my blood glucose test results to do anything 13 4.8 10 3.9 23 4.4
Monitor my blood glucose levels as I am trying to conceive N/A N/A 3 1.2 3 0.6
Monitor my blood glucose levels as I’m pregnant N/A N/A 3 1.2 3 0.6
Determine whether it is safe to drive 23 8.5 17 6.7 40 7.6
Don’t know 3 1.1 1 0.4 4 0.8
Total 658 - 696 - 1354 -
* Respondents were able to tick more than one answer; % figures are rounded
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diabetes, but as expected the number of those reporting
low usefulness was very low(n = 16).
The results did not differ statistically significantly
when sub-group analysis was conducted for duration of
diabetes, for male compared to female, or for frequent
users compared with occasional users, expect for self
chastisement issues being significantly higher for women
than men.
Responses to Out of Range Readings
Thematic analysis was conducted on free text responses
to out of range readings. The results are detailed in
Tables 6 and 7 below. Most patients responded to
abnormal levels by diet and physical activity, with few
adjusting medication, presumably because they could
only do if their doctor changed their prescription.
Responses to how participants felt when they experi-
enced out of range blood glucose readings are detailed
in Table 8 below.
Do you have any concerns/worries about self monitoring of
your blood glucose?
There were 525 responses to this question and of these,
89 (16.1%) expressed concerns or worries about self
monitoring. Whilst only 16.1% reported having con-
cerns/worries about SMBG on the questionnaire, the
results from the free text questions was much higher, i.
e. 27.3% (n = 135) of participants (out of the 495 who
provided a response) reported anxiety and worry asso-
ciated with blood glucose levels not being what they
expected them to be. Furthermore, 8.5% (n = 42)
reported feeling depressed, 13.7% (n = 68) not being in
control/low mood/upset/confused and 11.9% (n = 59)
felt frustrated/angry/guilty. Table 9 presents the actions
taken by participants in response to an unexpected
blood glucose reading.
Healthcare Professional Input
Who provided you with information about ...?
Most (74.7%, n = 211) participants reported that nurses
provided information about how to use their meter, fol-
lowed by 10.5% (n = 29) being informed by their doctor,
4.2% by a pharmacist and 11.0% reporting ‘other’. Simi-
larly, nurses suggested target blood glucose levels to
60.4% (n = 217) of participants, followed by doctors
(35.1%; n = 126); a single pharmacist, and others (4.2%;
n = 15). This pattern was repeated for information
about how often to monitor blood glucose levels
with nurses providing information to 65.0% (n = 208) of
Table 5 Helpfulness of SMBG (question 16)
1-10 Scale (1-extremely unhelpful, 10 very helpful) Male Female Total
N % N % N %
1 4 1.4 7 2.8 11 2.1
2 2 0.7 3 1.2 5 1.0
3 9 3.3 6 2.4 15 3.0
4 1 0.4 3 1.2 4 0.8
5 15 5.5 22 8.7 37 7.1
6 14 5.7 10 3.9 24 4.6
7 32 11.8 28 11.0 60 11.4
8 56 20.5 47 18.5 103 19.6
9 25 9.3 24 9.5 49 9.4
10 112 41.4 104 40.8 216 41.0
Total 270 100 254 100 524 100
* 524 respondents (94.6% of overall total)
Table 6 Free text responses to high blood glucose results
(question 13)
Thematic Codes Number of
Responses
Adjust diet/eat less 175
Exercise 98
Doesn’t happen/N/A 52
Do nothing 57
Test again later 45
Try to identify what caused it 38
Drink more fluids, particularly water 41
Unclear 31
Monitor food intake 33
Increase medication (oral anti-hyperglycaemic) 11
Consult or discuss with health care
professional
31
Eat more chocolate 1
Total 613
* 140 (out of 473) respondents gave more than one response to this question
** The quality check revealed a 5.7% discrepancy between the two analysts?.
These differences were resolved by consensus.
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participants, doctors to 31.9% (n = 102), pharmacist to
0.6% (n = 2) and other to 2.5% (n = 8).
Nurses were the main source (67.5%) of information
regarding what to do with the results, followed by, doc-
tors 29.6% (n = 72), pharmacists 1.2% (n = 3) and others
1.6% (n = 4). Similarly, advice on what to do when read-
ings were out of range information was provided by
nurses 62.3% (n = 152), doctors 35.7% (n = 87), pharma-
cists 0.4% (n = 1) and other 1.6% (n = 4).
Discussion
This group of confirmed users clearly value SMBG, and
use it for self-management.
There was a good response to the survey with over
500 responses received within the two week window
that the survey was live on the Diabetes UK website.
This was despite no formal requests for participation, or
marketing of the survey. Over three quarters of partici-
pants reported a high level of satisfaction with SMBG,
as indicated by a score of 7 or above on a scale of 1-10
assessing helpfulness of SMBG, with 41% scoring 10.
Despite this, there were mixed results from this group
of SMBG users. For example, most participants (84%)
reported having no concerns about SMBG, yet worry
and anxiety were frequently reported in the free text
responses. The dischord between questionaire answers
and free text regarding out of range readings is curious.
It could simply be that individuals perceived the ques-
tion to be associated with the technicalities of using the
device rather than interpreting the results. Or it could
be that the reported increased anxiety is more to do
with having Type 2 diabetes than the mechanism of
self-monitoring of blood glucose. Furthermore, when
readings are high and anxiety is increased, this emotion
may encourage a person to act in response to that high
reading.
It could be speculated that individuals newly diag-
nosed with Type 2 diabetes might be more likely to
adhere to healthcare professional advice regarding test-
ing frequency and what action to take based on the
results, but this was not supported in the results.
These results suggest that individuals are testing pre-
dominantly to evaluate the effect of a behaviour or diet-
ary change, with few (5.6%) using SMBG to alter their
diabetes medication. The latter finding may be because
few individuals are encouraged to alter their oral glu-
cose-lowering medication, with most leaving decisions
on medication to their healthcare professionals.
The only gender difference was that. women were
more likely to engage in self-chastisement than men
(p = < 0.001) and to report feelings of guilt associated
out of range readings. This finding reflects the qualita-
tive data presented by Clar and colleagues (2010) which
suggested that women tended to blame themselves for
out of range readings and reported higher levels of self-
chastisement. Men tended to rationalize such readings.
Previous SMBG literature has not explored gender dif-
ferences in increased anxiety/depression [4]
Limitations of the study include not having asked
participants about their HbA1c, which could have been
used to identify associations between frequency of test-
ing, levels of anxiety and biomedical control. There
is evidence to show, however, that the majority of
people with Type 2 diabetes do not know what their
Hb1c result is with only 2.9% being able to accurately
recall it [5].
Very few participants reported discussing these results
with their healthcare professional, although this does
not necessarily mean that they did not, simply that they
did not report doing so.
Table 7 Free text responses to low blood glucose result
Thematic Codes Number of
Responses
Eat/drink something 248
It doesn’t happen/N/A 168
Increase SMBG frequency/retest later 27
Do nothing 18
Response unclear 18
Consult/note in diary to discuss with healthcare
professional
9
Exercise 1
Increase starch intake 3
Total 492
* 34 (out of 460) respondents gave more than one response to this question
** The quality check revealed a 3.4% discrepancy between the two analysts.
Differeneces were resolved by consensus
Table 8 How do you feel when your blood glucose is not
as expected?
Thematic Codes Number of
Responses
Worried/anxious 135
In control/able to rationalize/determined to achieve
better diabetes control/better informed
135
It doesn’t happen/N/A 64
Frustrated/angry (with self and diabetes)/guilty 59
Disappointed 50
Not in control/low mood/upset/confused 68
Depressed 42
Physically unwell 16
Total 569
* 74 (out of 495) respondents gave more than one response to this question
* The quality check revealed a 4.2% discrepancy between the two reviewers.
Differences were resolved by consensus
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Limitations of the study include not having asked par-
ticipants about their HbA1c, which could have been
used to identify associations between frequency of test-
ing, levels of anxiety and biomedical control. We
expected respondents to be confirmed users and sup-
porters of SMBG, but another characteristic, given that
the survey was not advertised, must have been that they
are regular visitors to the Diabetes UK website. They
may therefore be a group of highly motivated “expert”
users. That raises implications for any increase in use of
SMBG, with one question being how best to motivate
others.
Other weaknesses of this survey are that it did not try
to link use of SMBG with outcomes. In retrospect, we
might have asked about frequency and severity of hypo-
glycaemic episodes; education received; and whether
that included structured education. However, it is prob-
able that this group consists mainly of effective self-
educators, so it might make no difference whether or
not they have attended a structured education course.
Nor did we ask whether the nurses involved were
practice nurses or diabetes specialist nurses, nor
whether diabetes care was provided mainly or solely in
primary care. In retrospect, we should also have asked
for more detail on oral drugs, and whether patients
were on monotherapy or combination therapy. Our
main interest in treatment reflected the remit of the DH
working group, and our aim was to exclude insulin-
users.
Research needs
It would be useful to see if frequent users had lower
HbA1c, and the effect of HbA1c results on anxiety. Is
anxiety more prevalent if SMBG users know that control
is unsatisfactory?
A key question is what distinguishes “effective
patients”. If we have a group of patients who are self-
motivated and who take control of their diabetes and its
management, what are their characteristics and how can
we motivate others to do likewise? Should structured
education for type 2 diabetes emphasise diet and physi-
cal activity more, and link SMBG with changes in life-
style, so that beneficial changes give positive feedback
via SMBG results?
The lack of any association between frequency of test-
ing, and perceived helpfulness, was curious, and may
reflect different aims of testing. Some may be testing
more often than necessary. Several observational studies
have reported on SMBG frequency and HbA1c and
SMBG use and outcomes [6-8] however there remains
inconsistency of reported benefit and/or effect.
Research is needed into whether more education on
how to interpret and act on out of range blood glucose
readings would improve control and reduce anxiety, and
on the optimal frequency of such education.
Conclusion
Our aim was to explore why some people with diabetes
are convinced that SMBG is helpful, in contrast to the
results of most of the trials. Over 80% of respondents
report high satisfaction with the usefulness of SMBG
and report feeling more ‘in control’ of their diabetes
management using it. They are the satisfied users. How-
ever a minority of users report feelings of anxiety and
depression and may be testing because they feel they
ought to, without achieving net benefit.
While recent cost-effectiveness analysis concludes that
SMBG is not cost-effective [9,1], nevertheless this may
not apply in selected groups of patients who make more
use of the data from SMBG. They may be gaining suffi-
cient benefit to make SMBG cost-effective, but quality
of life/utility measurement is needed to confirm this.
Appendix One: Copy of Questionnaire
SMBG questions for the website.
Thank you very much for taking the time to complete
our survey. Your answers are extremely valuable and
will help to inform ongoing work relating to self-moni-
toring blood glucose (SMBG) in people with Type 2 dia-
betes like yourself.
Table 9 Actions Taken if blood glucose levels not as expected
Action Male Female Total
N % N % N %
I increased my medication 24 8.9 18 7.1 42 8.0
I reduced my carbohydrate for the same mealtime the next day 167 61.6 153 60.2 320 61.0
I did more physical activity than I would normally do 106 39.1 87 34.3 193 36.8
I contacted my diabetes healthcare team for advice 36 13.3 30 11.8 66 12.6
I didn’t do anything 54 19.9 60 23.6 114 21.7
Other 21 7.8 17 6.7 38 7.2
Total 408 - 365 - 773 -
* Respondents were able to tick more than one answer
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The survey is particularly aimed at people with Type 2
diabetes, who are not treated with insulin, to try and
find out how people use SMBG and the impact it has
on their day-to-day diabetes management.
Please be aware that the survey should take approxi-
mately 10 minutes. It would be very helpful if you could
try to answer as many questions as possible.
1. Are you...
Male?
Female?
2. Do you have Type 2 diabetes?
Yes
No
If you answered Yes, go to question 3.
If you answered No please do not continue with
the survey, thank you for your time.
3. How long has it been since you were diagnosed
with Type 2 diabetes?
0-6 months
Between 6 months and 1 year
Between 1 and 3 years
Between 3 and 5 years
More than 5 years
4a. Is your diabetes treated with insulin?
Yes
No
If you answered Yes, please go to question 4b
If you answered No, please go to question 5
4b. Is your diabetes treated with insulin and other
medications?
Yes
No
If you answered Yes, please do not continue with
the survey, thank you very much for your time.
If you answered No, please go to question 5
5. Do you monitor your blood glucose levels using
your own meter?
Yes
No
If yes go to question 6
If no, could you please say why you don’t moni-
tor your blood glucose levels?
- I monitor my glucose levels using urine testing
- I have not been advised to do so
- Other reason, please specify:
6. Typically how often do you monitor your blood
glucose levels (please
tick all that apply)?
Once a day
Twice a day
Three times a day
Four times a day
More than four times a day, please state how
many times a day:
Once a week
More than once a week
Fortnightly
Less than once a month
Occasional periods - monitoring frequently for a
few days
Don’t know
Other, please specify:
7. Typically when do you test your blood glucose
levels?
(please tick all relevant responses)
Before meals
2 hours after meals
Before going to bed
During episode(s) of illness
Before I set off to drive
If I feel that I am having a hypoglycaemic
episode
If I feel my blood glucose level is higher than it
should be
Before I start any physical activity
During physical activity
After I have finished any physical activity
A change in my treatment is being considered
To monitor the effect of certain foods
Other, please specify:
8. Which of the following if any, do you use your
blood glucose test results
to do? (please tick all relevant responses):
to monitor my health as I have recently been
diagnosed with diabetes
to make adjustments to my food intake
when assessing the impact of physical activity
to confirm if I’m having a hypoglycaemic episode
to confirm if I have a high blood glucose level
to alter my diabetes medication
to inform me about the effect of a new diabetes
medication I’ve started
to inform me about my blood glucose levels dur-
ing a period of illness
I don’t use my blood glucose test result(s) to do
anything
to monitor my blood glucose levels as I am try-
ing to conceive
to monitor my blood glucose levels as I’m
pregnant
to determine whether it is safe to drive
Don’t know
Other, please specify:
9. If you get a high blood glucose result, for example
above 10 millimoles
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per litre (mmols/l), what do you do to respond
to that reading?
10. If you get a low blood glucose result(s), for
example below 4 millimoles
per litre (mmols/l) result, how do you deal with
it?
11. Do you have any concerns/worries about self
monitoring your blood glucose levels?
Yes
No
Don’t know
If you answered Yes, what are your concerns?
12. On a scale of 1 to 10, with 1 meaning extremely
unhelpful and 10 meaning extremely helpful, how
helpful or unhelpful do you find self-monitoring
blood glucose (SMBG)?
1..2..3..4..5..6..7..8..9..10
If you answered 7 or above, please say why you find
it so helpful (tick all that apply below and any addi-
tional reasons):
- improved my diabetes control
- weight control
- helped to avoid episodes of hypoglycaemia
- better able to undertake physical activity
- helped me during an episode of illness
- other (please specify)
If you answered 4 or below, please say why you
don’t find it helpful (please list all of your reasons):
- it is painful
- my healthcare team doesn’t look at the results
- it is a reminder of illness
- sometimes, I just don’t want to self-monitor
blood glucose
- it discouraged me from making any changes to
my lifestyle
- other
13. How does it make you feel if your blood glucose
levels were not what you expected them to be?
14. If your blood glucose levels were not what you
expected, which of the following actions, if any did
you do?
- I adjusted my medication
- I did more physical activity
- I adjusted my carbohydrate for the same meal-
time the next day
- I didn’t do anything
- I contacted a member of my diabetes health-
care team for advice, please state
who this was:
- other, please specify:
15. Do you discuss these results with and/or receive
any education from any of your diabetes healthcare
team, for example nurse, pharmacist, doctor about
any of the following?
- How to use your meter?
Yes
No
I don’t know
If yes, who provided you with this information?
Nurse/pharmacist/doctor/other
- Information about what your own target blood glu-
cose ranges are?
Yes
No
I don’t know
If yes, who provided you with this information?
Nurse/pharmacist/doctor/other
- Advice about when to monitor your blood glucose
levels?
Yes
No
I don’t know
If yes, who provided you with this information?
Nurse/pharmacist/doctor/other
- Advice about how often to monitor your blood
glucose levels?
Yes
No
I don’t know
If yes, who provided you with this information?
Nurse/pharmacist/doctor/other
- Advice about what to do with your blood glucose
results?
Yes
No
I don’t know
If yes, who provided you with this information?
Nurse/pharmacist/doctor/other
- Advice about what to do if your blood glucose
results were outside of your agreed target range?
Yes
No
I don’t know
If yes, who provided you with this information?
Nurse/pharmacist/doctor/other
End
Abbreviations
GP: General Practitioner; HbA1c: Haemaglobin A1c; HCP: Healthcare
Professional; SMBG: Self Monitoring of Blood Glucose
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